Feb 19,2021

MyWay Digital Health Finalist in Digital Tech 2019 Awards

The ScotlandIS Digital Technology Awards 2019 showcase excellence within the industry rewarding the innovation, expertise and ambition of businesses large and small – and the people who drive them. MyWay Digital Health has been shortlisted in the emerging Digital Technology Business of the year category, along with ChilliConnect and Wobbegong Technology Ltd.

View Analyst & Ambassador Comments
Go to original news
Mar 01,2019

Flash glucose monitoring improves glycemia in higher risk patients: a longitudinal, observational study under real-life settings

Deidentified glucose results from 6802 flash glucose monitors were analyzed after dividing into high, medium and low-risk groups based on tertiles of time spent in hypoglycemia (min/day <70 mg/dL) or hyperglycemia (hours/day >240 mg/dL). Groups were further subdivided into tertiles of glucose scanning frequency and glycemic measures analyzed in the first 14 days and over 6 months.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 05,2019

Novo Nordisk Pharma Ltd. and Health2Sync partner in Japan to expand digital diabetes management to healthcare providers and patients

Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localisation and promotion of the “SyncHealth” App (known as Health2Sync outside of Japan) and web platform for patient management. As part of the partnership, Novo Nordisk Pharma Ltd. will support the distribution and adoption of the SyncHealth app and healthcare provider platform in Japan. In the future, Novo Nordisk Pharma Ltd. aims to wirelessly connect its insulin delivery devices, enabling auto data recording of self-injected insulin. 

COLLABORATION PARTNERSHIP

#product & service

#mobile app

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Mar 06,2019

Voluntis receives CE Mark to add NPH/isophane to Insulia

Today, Voluntis announced that it had obtained the CE mark for the new version of Insulia that integrates intermediate-acting neutral protamine Hagedorn (NPH) insulin, also known as isophane insulin. Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of basal insulin, including NPH insulin as well as all first and second generation long-acting basal insulin analogs.

REGULATORY CE MARK

#dtx

View Analyst & Ambassador Comments
Go to original news
Mar 06,2019

Tandem Diabetes Care Announces Upcoming Conference Presentations

The presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Mar 06,2019

Tandem Diabetes Care Announces Plan to Use Remote Software Update Tool in Ongoing Clinical Trial

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly identified during the ongoing DCLP3 phase of the International Diabetes Closed Loop (IDCL) clinical trial. The Company anticipates that the software update will be available to study sites before the end of March.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Mar 07,2019

Tandem Diabetes Care Approved as Insulin Pump Vendor for ADP in Ontario, Canada

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario, Canada. The t:slim X2 insulin pump features Dexcom G5® Mobile continuous glucose monitoring (CGM) integration, making it the only CGM-integrated insulin pump approved in Canada for making daily diabetes treatment decisions without fingersticks.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 12,2019

Nemaura Medical Announces Exclusive License and Supply Agreement for SugarBEAT® in the GCC Region

Nemaura Medical, Inc., a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced that it has signed an exclusive license and supply agreement for SugarBEAT® with TPMENA in the Gulf Cooperation Council (GCC) Region, which includes Bahrain, Kuwait, Saudi Arabia, Oman and United Arab Emirates.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 12,2019

Computerized Systems for Managing Glucose Will Become Standard of Care in Hospitals, Anticipates Dr. Bruce Bode

A presentation at ATTD 2019 by renowned diabetologist and researcher, Dr. Bruce Bode, showcased superior clinical and financial outcomes with Glytec’s eGlycemic Management System® versus usual care across multiple studies.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Mar 12,2019

Digital Health Veteran Derek Newell and Organizational Behavior Expert Lucia Guillory Join Virta Health

Derek Newell, former director and president of Castlight Health and CEO of the health benefits platform Jiff, is joining as Virta’s Head of Commercial. Lucia Guillory joins as Virta’s Head of People, having previously held the same role at Patreon.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES